Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baronti, F.
Right arrow Articles by Chase, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baronti, F.
Right arrow Articles by Chase, T. N.
NEUROLOGY 1992;42:1241
© 1992 American Academy of Neurology

Partial dopamine agonist therapy of levodopa-induced dyskinesias

F. Baronti, MD, M. M. Mouradian, MD, K. E. Conant, MD, M. Giuffra, MD, G. Brughitta, MD and T. N. Chase, MD

Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

We administered the partial dopamine agonist terguride under controlled conditions to patients with Parkinson's disease (PD), both as monotherapy and in conjunction with intravenous levodopa. Terguride produced a dose-dependent decrease in levodopa-induced dyskinesias (up to 53%) in seven patients without concomitant worsening of parkinsonism, and had no significant antiparkinsonian effect when administered alone. Partial dopamine agonists may hold some promise in the adjuvant therapy of patients with advanced PD.

Address correspondence and reprint requests to Dr. Thomas N. Chase, Bldg. 10, Room 5C103, National Institutes of Health, Bethesda, MD 20892.

Received September 9, 1991. Accepted for publication in final form November 18, 1991.




This article has been cited by other articles:


Home page
 NeurologyHome page
A. J. Manson, A. Schrag, and A. J. Lees
Low-dose olanzapine for levodopa induced dyskinesias
Neurology, September 26, 2000; 55(6): 795 - 799.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Pulvirenti, C. Balducci, M. Piercy, and G. F. Koob
Characterization of the Effects of the Partial Dopamine Agonist Terguride on Cocaine Self-Administration in the Rat
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1231 - 1238.
[Abstract] [Full Text]

Home page
 NEJMHome page
D. B. Calne
Treatment of Parkinson's Disease
N. Engl. J. Med., September 30, 1993; 329(14): 1021 - 1027.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by AAN Enterprises, Inc.